Sort
82,697 grants matching “vaccine development”
City of Hope Lymphoma SPORE
$2,324,999Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2019 · CA
SPORE in Gastrointestinal Cancers
$2,324,999Alison P Klein · Johns Hopkins University · P50 · FY2019 · CA
City of Hope Lymphoma SPORE
$2,324,819Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2021 · CA
Center for Cancer Immunology and Immunotherapy (CCII)
$2,324,733Jun Yan · University Of Louisville · P20 · FY2021 · GM
Understanding the Basis for Cellular Diversity During Adaptive Immunity
$2,323,773John T Chang · University Of California, San Diego · DP2 · FY2011 · OD
Robust T-cell Immunity to Influenza in Human Populations
$2,322,971Jack A Gorski · Versiti Wisconsin, Inc. · U19 · FY2007 · AI
Characterization of novel genes encoded ty RNA and DNA viruses
$2,322,470Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2016 · AI
Tulane National Primate Research Center AIDS SPF Breeding Colony Maintenance
$2,322,401Kasi E Russell-Lodrigue · Tulane University Of Louisiana · U42 · FY2025 · OD
SPORE in Brain Cancer
$2,322,240Darell D Bigner · Duke University · P50 · FY2007 · CA
MBRS-SCORE PROGRAM AT UPR, MEDICAL SCIENCES CAMPUS
$2,322,206University Of Puerto Rico Med Sciences · S06 · FY2002 · GM
Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine
$2,321,982Louis J. Picker · Oregon Health & Science University · U19 · FY2020 · AI
Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine
$2,321,982Louis J. Picker · Oregon Health & Science University · U19 · FY2019 · AI
Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine
$2,321,982Louis J. Picker · Oregon Health & Science University · U19 · FY2018 · AI
Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine
$2,321,981Louis J. Picker · Oregon Health & Science University · U19 · FY2021 · AI
Robust T-cell Immunity to Influenza in Human Populations
$2,321,915Jack A Gorski · Versiti Wisconsin, Inc. · U19 · FY2008 · AI
Virus-Host Interactions: Induction and Evasion of Host Innate Immunity
$2,321,780Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT
$2,321,603David Montefiori · Duke University · N01 · FY2020 · AI
Protective Immunity
$2,321,479David I Watkins · University Of Miami School Of Medicine · P01 · FY2016 · AI
NIAID Preclinical Development Support
$2,321,304Nancy Lin · Advanced Bioscience Laboratories, Inc. · N01 · FY2015 · AI
Ecopathogenomics of sexually transmitted infections (EPSTI)
$2,320,963Patrik M Bavoil · University Of Maryland Baltimore · U19 · FY2015 · AI
University of Puerto Rico Clinical Trials Unit
$2,320,253Carmen D Zorrilla · University Of Puerto Rico Med Sciences · U01 · FY2008 · AI
Tuberculosis Imaging Program
$2,320,134Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIC · FY2020 · AI
Influenza vaccination using a microneedle patch
$2,319,850Mark R Prausnitz · Georgia Institute Of Technology · U01 · FY2013 · EB
FOOD AND WATERBORNE DISEASES INTEGRATED RESEARCH NETWORK
$2,319,677University Of Maryland Baltimore · N01 · FY2010 · AI
Epidemiology and Prevention Interdisciplinary Center for Sexually Transmitted Inf
$2,319,395Cosette Marie Wheeler · University Of New Mexico Health Scis Ctr · U19 · FY2018 · AI